Core Viewpoint - scPharmaceuticals Inc. is set to host a conference call on August 7, 2025, to discuss its Q2 2025 financial results and provide a business update [1]. Company Overview - scPharmaceuticals is focused on revolutionizing cardiorenal healthcare through patient-centric innovations [1][3]. - The company's mission emphasizes advancing cardiorenal care with innovative, integrated treatments that address unmet patient needs [3]. - scPharmaceuticals aims to be a leading advocate for patient-centric cardiorenal care, promoting global health improvements through specialized, multidisciplinary approaches [4]. - The company is headquartered in Burlington, MA, and is expanding its reach with integrated therapies and products to improve patient lives [4].

BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that John Tucker, President and Chief Executive Officer, will participate in the following upcoming investor conferences: The Citizens Life Sciences Conference: Presentation on Wednesday, May 7 at 9:30 a.m. ET.Craig-Hallum 22nd Annual Institutional Investor Conference: Wedne ...